Furthermore, DAB2IP can prevent the progression of prostate cancer [5, 9] by inhibiting epithelial-to-mesenchymal transition (EMT) via Wnt-elicited β-catenin pathway. This evidence concerns the gene DAB2IP and Familial prostate cancer.